BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38553931)

  • 1. Audit on data accuracy of the Malaysian Dialysis and Transplant Registry (MDTR).
    Thong KM; Jalalonmuhali M; Choo CL; Yee SY; Yahya R; Jeremiah PN; Bavanandan S; Hooi LS
    Med J Malaysia; 2024 Mar; 79(2):234-236. PubMed ID: 38553931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal replacement therapy in Brunei Darussalam: comparing standards with international renal registries.
    Tan J
    Nephrology (Carlton); 2014 May; 19(5):288-95. PubMed ID: 24641721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in excess mortality among adults with diabetes-related end-stage kidney disease: a comparison between the USA and Australia.
    Harding JL; Morton JI; Shaw JE; Patzer RE; McDonald SP; Magliano DJ
    Nephrol Dial Transplant; 2022 Sep; 37(10):2004-2013. PubMed ID: 34724066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Data quality of the Australia and New Zealand Dialysis and Transplant Registry: a pilot audit.
    Gray NA; Mahadevan K; Campbell VK; Noble EP; Anstey CM
    Nephrology (Carlton); 2013 Oct; 18(10):665-70. PubMed ID: 23841726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. End-stage kidney disease due to Alport syndrome: outcomes in 296 consecutive Australia and New Zealand Dialysis and Transplant Registry cases.
    Mallett A; Tang W; Clayton PA; Stevenson S; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Campbell SB; Johnson DW
    Nephrol Dial Transplant; 2014 Dec; 29(12):2277-86. PubMed ID: 25061124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.
    Zhang L; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; De Zoysa J; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW
    Nephrology (Carlton); 2016 May; 21(5):387-96. PubMed ID: 26393772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes of patients with end-stage kidney disease due to membranous nephropathy: A cohort study using the Australia and New Zealand Dialysis and Transplant Registry.
    Yang WL; Bose B; Zhang L; Mcstea M; Cho Y; Fahim M; Hawley CM; Pascoe EM; Johnson DW
    PLoS One; 2019; 14(8):e0221531. PubMed ID: 31442267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of diabetes and chronic dialysis on post-transplant survival in combined heart-kidney transplant recipients.
    Parekh JR; Lam J; Chau H; Berumen J; Schnickel GT; Mekeel K
    Clin Transplant; 2021 Jul; 35(7):e14338. PubMed ID: 33948985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A report of the Malaysian dialysis registry of the National Renal Registry, Malaysia.
    Lim YN; Lim TO; Lee DG; Wong HS; Ong LM; Shaariah W; Rozina G; Morad Z
    Med J Malaysia; 2008 Sep; 63 Suppl C():5-8. PubMed ID: 19230240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost utility analysis of end stage renal disease treatment in Ministry of Health dialysis centres, Malaysia: Hemodialysis versus continuous ambulatory peritoneal dialysis.
    Surendra NK; Abdul Manaf MR; Hooi LS; Bavanandan S; Mohamad Nor FS; Firdaus Khan SS; Meng OL; Abdul Gafor AH
    PLoS One; 2019; 14(10):e0218422. PubMed ID: 31644577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating data quality in the Australian and New Zealand dialysis and transplant registry using administrative hospital admission datasets and data-linkage.
    Palamuthusingam D; Pascoe EM; Hawley CM; Johnson DW; Ratnayake G; McDonald S; Boudville N; Jose M; Fahim M
    Health Inf Manag; 2023 Sep; 52(3):212-220. PubMed ID: 35695032
    [No Abstract]   [Full Text] [Related]  

  • 12. Type 2 diabetes in patients with end-stage kidney disease: influence on cardiovascular disease-related mortality risk.
    Lim WH; Johnson DW; Hawley C; Lok C; Polkinghorne KR; Roberts MA; Boudville N; Wong G
    Med J Aust; 2018 Nov; 209(10):440-446. PubMed ID: 30332936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absolute risk and risk factors for stroke mortality in patients with end-stage kidney disease (ESKD): population-based cohort study using data linkage.
    De La Mata NL; Alfaro-Ramirez M; Kelly PJ; Masson P; Al-Shahi Salman R; Webster AC
    BMJ Open; 2019 Feb; 9(2):e026263. PubMed ID: 30798318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and genetic risk factors for new-onset diabetes mellitus after transplantation (NODAT) in major transplant centres in Malaysia.
    Guad RM; Taylor-Robinson AW; Wu YS; Gan SH; Zaharan NL; Basu RC; Liew CSL; Wan Md Adnan WAH
    BMC Nephrol; 2020 Sep; 21(1):388. PubMed ID: 32894076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Using Dialysis and Transplantation Registries for regional and small-area epidemiology].
    Vitullo F
    G Ital Nefrol; 2003; 20(2):151-9. PubMed ID: 12746800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. End-stage kidney disease due to haemolytic uraemic syndrome--outcomes in 241 consecutive ANZDATA registry cases.
    Tang W; Mohandas J; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Clayton PA; Wiggins KJ; Bannister KM; Campbell SB; Johnson DW
    BMC Nephrol; 2012 Dec; 13():164. PubMed ID: 23206870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes and Cardiovascular Risk in Renal Transplant Patients.
    Rysz J; Franczyk B; Radek M; Ciałkowska-Rysz A; Gluba-Brzózka A
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association Between Age of Onset of Type 2 Diabetes and the Long-term Risk of End-Stage Kidney Disease: A National Registry Study.
    Morton JI; Liew D; McDonald SP; Shaw JE; Magliano DJ
    Diabetes Care; 2020 Aug; 43(8):1788-1795. PubMed ID: 32540924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal replacement therapy in patients with diabetic nephropathy, 1980-1985. Report from the European Dialysis and Transplant Association Registry.
    Brunner FP; Brynger H; Challah S; Fassbinder W; Geerlings W; Selwood NH; Tufveson G; Wing AJ
    Nephrol Dial Transplant; 1988; 3(5):585-95. PubMed ID: 3146713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in Nonmelanoma Skin Cancer Incidence by Treatment Modality Among Patients Receiving Multiple Kidney Transplants.
    Sexton DJ; O'Kelly P; O'Leary E; Murray S; Deady S; Daly F; Egan J; Houlihan DD; McCormick PA; Morris PG; Ni Raghallaigh S; Moloney FJ; O'Neill JP; Conlon PJ
    JAMA Dermatol; 2019 May; 155(5):594-598. PubMed ID: 30725084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.